## Abstract Non‐nucleoside reverse transcriptase inhibitors (NNRTIs) are part of the preferred treatment regimens for individuals infected with HIV. These NNRTI‐based regimens are efficacious, but the most popular NNRTIs have a low genetic barrier to resistance and have been associated with adverse
✦ LIBER ✦
Cover Picture: Diphenyl Ether Non-Nucleoside Reverse Transcriptase Inhibitors with Excellent Potency Against Resistant Mutant Viruses and Promising Pharmacokinetic Properties (ChemMedChem 1/2009)
✍ Scribed by Zachary K. Sweeney; Joshua J. Kennedy-Smith; Jeffrey Wu; Nidhi Arora; J. Roland Billedeau; James P. Davidson; Jennifer Fretland; Julie Q. Hang; Gabrielle M. Heilek; Seth F. Harris; Donald Hirschfeld; Petra Inbar; Hassan Javanbakht; Jesper A. Jernelius; Qingwu Jin; Yu Li; Weiling Liang; Ralf Roetz; Keshab Sarma; Mark Smith; Dimitrio Stefanidis; Guoping Su; Judy M. Suh; Armando G. Villaseñor; Michael Welch; Fang-Jie Zhang; Klaus Klumpp
- Book ID
- 102806181
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 879 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Diphenyl Ether Non-Nucleoside Reverse Tr
✍
Zachary K. Sweeney; Joshua J. Kennedy-Smith; Jeffrey Wu; Nidhi Arora; J. Roland
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 521 KB